abstract |
The present invention relates to novel 1-benzyl-3-hydroxymethylindazoles derivatives according to formula (I) as described in the claims, and pharmaceutical compositions comprising them together with pharmaceutical excipients. The present invention also relates to the use of 1-benzyl-3-hydroxymethyl indazole derivatives for the preparation of a pharmaceutical composition effective for the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 and to the use of MCP-1, CX3CR1 And methods of treating or preventing diseases based on the expression of p40. |